These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9830966)

  • 41. The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial sampling.
    Goudevenos JA; Bairaktari ET; Chatzidimou KG; Milionis HJ; Mikhailidis DP; Elisaf MS
    Curr Med Res Opin; 2001; 16(4):269-75. PubMed ID: 11268711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
    Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
    Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Atorvastatin (Lipitor): a review of its pharmacological and clinical profile].
    Funatsu T; Kakuta H; Tanaka H; Arai Y; Suzuki K; Miyata K
    Nihon Yakurigaku Zasshi; 2001 Jan; 117(1):65-76. PubMed ID: 11233299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Atorvastatin].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract]   [Full Text] [Related]  

  • 46. Statin therapy works for patients who have type 2 diabetes.
    Korber KE
    JAAPA; 2008 Oct; 21(10):58, 60. PubMed ID: 19024640
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
    Ando H; Sugimoto K; Yanagihara H; Tsuruoka S; Saito T; Takamura T; Kaneko S; Fujimura A
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1012-7. PubMed ID: 18430053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Pincus J
    Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683
    [No Abstract]   [Full Text] [Related]  

  • 49. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel mechanism of action of atorvastatin against cardiovascular risk: a commentary on "decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins".
    Emanuele E; Geroldi D
    Free Radic Biol Med; 2007 Nov; 43(9):1231-2. PubMed ID: 17893035
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia.
    Akin F; Ayça B; Köse N
    Angiology; 2014 Aug; 65(7):651. PubMed ID: 24535640
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.
    Rosales A; Alvear M; Cuevas A; Saavedra N; Zambrano T; Salazar LA
    Clin Chim Acta; 2012 Feb; 413(3-4):495-501. PubMed ID: 22120734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic approach to the study of statin pleiotropy in kidney transplant patients.
    Pérez V; Navarro-Muñoz M; Mas S; Bayés B; Pastor MC; Martínez-Cáceres E; Lauzurica R; Egido J; Romero R
    Pharmacology; 2011; 87(3-4):161-8. PubMed ID: 21372619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mean platelet volume measurement in patients with hypercholesterolemia: a methodological issue.
    Varol E; Ozaydin M
    Angiology; 2013 Nov; 64(8):626. PubMed ID: 23709475
    [No Abstract]   [Full Text] [Related]  

  • 55. Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk.
    Kadoglou NP; Vrabas IS; Kapelouzou A; Lampropoulos S; Sailer N; Kostakis A; Liapis CD
    Regul Pept; 2011 Oct; 170(1-3):57-61. PubMed ID: 21640762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl.
    Wassmann S; Ribaudo N; Faul A; Laufs U; Böhm M; Nickenig G
    Am J Cardiol; 2004 Jan; 93(1):84-8. PubMed ID: 14697473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A low-density lipoprotein-dependent effect of atorvastatin upon the systolic blood pressure reduction: meta-regression analyses of randomized trials.
    Takagi H; Umemoto T;
    Int J Cardiol; 2013 Dec; 170(1):e14-6. PubMed ID: 24169537
    [No Abstract]   [Full Text] [Related]  

  • 58. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
    Chong PH; Seeger JD
    Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins?
    Patterson D; Dick JB; Struthers AD
    Heart; 2002 Oct; 88(4):415-6. PubMed ID: 12231607
    [No Abstract]   [Full Text] [Related]  

  • 60. [IMPROVE-IT Study proves effectiveness of ezetimib. The Higgs particle of lipidologists].
    Einecke D
    MMW Fortschr Med; 2014 Dec; 156(21-22):24-6. PubMed ID: 25608385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.